Dr. Vince Clinical Research
  • Home
  • About
    • Company Brochure
    • Leadership Team
    • Vision
    • Envisioned Around Technology
    • Green Certification
    • Careers
    • Photo Gallery
  • Services
    • Clinical Pharmacology Unit
    • Study Types
    • Support Services
    • Clinical Laboratory
  • Resources
    • Blogs
    • Brochure
    • Fact Sheets
    • Publications
    • Videos
    • Webinars
    • White Papers
  • News
  • Contact Us
  • Volunteer Website
  • Request Information
Select Page

Cingulate Completes Fed/Fast Study Assessing Food Effect with CTx-1301, Lead Candidate for Treatment of ADHD

Press Releases

Study Conducted by Dr. Vince Clinical Research KANSAS CITY, Kan., Nov. 01, 2022 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and...

Recent Posts

  • Full-Service CRO Overview
  • Acute Pain Models in Drug Development
  • Dr. Vince Clinical Research Expands Campus with New Administration Building
  • 10 Lessons Learned Over 40 Years of Drug Development Research in Psychiatry
  • Effective Study Design and Execution of Renal and Hepatic Impairment Trials

Recent Comments

    Contact Us

    (913) 333-3000

    Headquarters

    7401 W. 91st Street
    Overland Park, KS
    66212 USA

    ABOUT

    • Company Brochure
    • Leadership Team
    • Vision
    • Envisioned Around Technology
    • Green Certification
    • Photo Gallery

    SERVICES

    • Clinical Pharmacology Unit
    • Study Types
    • Support Services
    • Clinical Laboratory

    RESOURCES

    NEWS

    Dr. Vince Clinical Research Logo

    Connect with us!

    • Follow
    • Follow
    Contact Us Today

    Privacy Policy | Terms & Conditions